Skip to main content
. 2017 Apr 4;8:132. doi: 10.3389/fphar.2017.00132

Figure 6.

Figure 6

Western blots of PPAR-γ and BDNF in mammary tumors. Western blots of PPAR-γ and BDNF levels in mammary tumors after combined treatment of curcumin and cisplatin in breast cancer rats. Where lane a is breast cancer control, b is curcumin, c is cisplatin, and d is Curcumin + Cisplatin. Results were normalized with respect to actin. Similar results were obtained in three independent set of experiments. All values were expressed as mean ± SEM (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001; a vs. breast cancer control & b vs. cisplatin.

HHS Vulnerability Disclosure